204 related articles for article (PubMed ID: 3677082)
1. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
[TBL] [Abstract][Full Text] [Related]
2. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma.
Coderre JA; Glass JD; Fairchild RG; Micca PL; Fand I; Joel DD
Cancer Res; 1990 Jan; 50(1):138-41. PubMed ID: 2293547
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of a murine melanoma.
Coderre JA; Kalef-Ezra JA; Fairchild RG; Micca PL; Reinstein LE; Glass JD
Cancer Res; 1988 Nov; 48(22):6313-6. PubMed ID: 3180048
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
7. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
[TBL] [Abstract][Full Text] [Related]
9. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
10. [Neutron capture therapy for cancer].
Fukuda H; Ichihashi M; Mishima Y
Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
[TBL] [Abstract][Full Text] [Related]
12. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
[TBL] [Abstract][Full Text] [Related]
13. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
14. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
[TBL] [Abstract][Full Text] [Related]
15. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.
Coderre JA; Slatkin DN; Micca PL; Ciallella JR
Radiat Res; 1991 Nov; 128(2):177-85. PubMed ID: 1947013
[TBL] [Abstract][Full Text] [Related]
17. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
18. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
19. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
[TBL] [Abstract][Full Text] [Related]
20. Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma.
Fairchild RG; Greenberg D; Watts KP; Packer S; Atkins HL; Som P; Hannon SJ; Brill AB; Fand I; McNally WP
Cancer Res; 1982 Feb; 42(2):556-62. PubMed ID: 7055803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]